Verde Media Group Inc. Advances New Science For The Medical and Cosmetic Industry

LOS ANGELES, April 2, 2014 /PRNewswire/ -- Verde Media Group Inc. (OTC: VMGI) Verde Media Group Inc. is pleased to announce that it is has entered into the medical and cosmetics industry through its newly created subsidiary Beautyject Inc. Beautyject is in final negotiations to in-license a unique proprietary needleless technology redefining known delivery methods.

Beautyject is in advanced discussions with a major group for the sale and distribution of its needleless delivery system throughout North America. Upon completion of this agreement management expects revenues from the sale of this system will generate upwards of $25M in its first year of commercialization.

The technology allows individuals to inject various solutions that reduce and remove skin wrinkles without the use of any needles as one of the many uses that will be employed with the Beautyject system. The injectors have a long shelf life and are virtually painless avoiding blood vessel and nerve damage associated with repetitive needle injections. The Verde Media Biotech Division (VMBD) further plans to extend the application to $240B anti-aging industry including painless injections of growth hormone and collagens that often require daily injections.

William Veve, President of Verde Media Group, Inc. stated, "The addition of Beautyject to the Verde family is a significant milestone for our company as we advance our business plan for rapid growth."

About Verde Media Group Inc.

Verde Media Group Inc. is a publicly traded company listed on the OTC Markets trading under the stock symbol: VMGI. Verde Media Group Inc.  The Company consists of three divisions:

Agency Division-  The innovative Agency division services- public relations, marketing, sales and transaction functions for corporate clientele.  The agency is rapidly expanding its business in the Denver, Colorado market that will become the largest legal retail marijuana sector.

BioTech Division- The VMBD division undertakes the business of developing and producing high value bio-products from renewable biomass.  The focus and criterion is to develop proprietary microbial technologies with low risk scale-up methods employing low cost feedstock.  VMBD will further develop the derivative and ester forms of THC for increase in potency and their use in different delivery systems, including sublingual, inhaled dosage forms and blending with food products.

Entertainment Division-  The Company operates a managed media company with production, distribution, development, and acquisition functions for film and television.

For more information, visit www.verdemediagroup.com, or connect with the company on Facebook. Twitter- @Verdemediagroup

DISCLAIMER: CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
The results described herein cannot be guaranteed. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this news release other than statements of historical fact are "forward-looking statements" that are based on current expectations and assumptions.

Logo - http://photos.prnewswire.com/prnh/20140219/PH68218LOGO

SOURCE Verde Media Group Inc.